During the past decade, Neurologie im Tempelhofer Hafen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurologie im Tempelhofer Hafen" are "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Neurologie im Tempelhofer Hafen" in a lesser frequency.

Most popular intervention types in "Neurologie im Tempelhofer Hafen" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurologie im Tempelhofer Hafen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurologie im Tempelhofer Hafen". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Neurologie im Tempelhofer Hafen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurologie im Tempelhofer Hafen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".